Your Body Is Quietly on Fire

Your Body Is Quietly on Fire

You don't feel it. That's the problem. Chronic, low-grade inflammation has no obvious symptoms. No temperature, no redness, no sharp pain. It builds quietly, underneath everyday life, for months or years. And the scientific consensus is increasingly clear: it is one of the most significant drivers of modern disease.

It is associated with cardiovascular disease. With type 2 diabetes. With cognitive decline. And it is implicated in the progression of cancer. Not always as a consequence, but increasingly understood as a contributing cause.

The Switch That Won't Turn Off

Inflammation is not the enemy. It is a biological defence system, and acute inflammation is essential. It heals wounds, fights infection, and protects tissue. The trouble begins when the body's inflammatory "on switch", a signalling molecule called NF-kB, stays activated long after the threat has passed.

NF-kB sits at the centre of the inflammatory response. When it fires, it triggers the release of pro-inflammatory cytokines such as TNF-alpha, IL-6 and IL-1beta. In acute inflammation this is appropriate and time-limited. In chronic inflammation it can become a self-sustaining loop, driven by stress, poor sleep, processed food and environmental load, producing cellular damage, neuroinflammation and systemic strain.

Chronic inflammation is associated with cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders. Contato & Conte-Junior, Nutrients, 2025

Two further pathways tend to compound the problem. COX-2 drives the synthesis of prostaglandin E2, a key mediator of pain and inflammation, while iNOS produces nitric oxide, which at elevated levels is linked to oxidative stress and mitochondrial dysfunction. Together, these three systems form much of the machinery of chronic inflammation.

What the Research Shows

A 2025 narrative review published in Nutrients (Contato and Conte-Junior, Federal University of Rio de Janeiro) synthesised the current evidence on Hericium erinaceus, Lion's Mane, with particular focus on its anti-inflammatory and antioxidant mechanisms. What stands out is the breadth of action.

In the laboratory models reviewed, Lion's Mane did not appear to target a single pathway. It appeared to influence three at once, which is unusual among natural compounds.

  • NF-kB inhibition. Erinacines and hericenones were observed to block the phosphorylation of IkBalpha, preventing NF-kB activation and reducing the transcription of TNF-alpha, IL-6 and IL-1beta.
  • COX-2 and iNOS suppression. Hericenones inhibited COX-2, lowering prostaglandin E2 synthesis. Lion's Mane also suppressed iNOS expression, reducing the nitric oxide production tied to chronic oxidative stress.
  • Nrf2 pathway activation. By activating Nrf2 (nuclear factor erythroid 2-related factor 2), Lion's Mane upregulated the body's own antioxidant defence enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx).

The Nrf2 finding is especially interesting. Most anti-inflammatory interventions work purely by suppression. Nrf2 activation is different: it recruits the body's endogenous antioxidant systems, supporting cellular defence rather than simply dampening the immune response.

The Compounds Doing the Work

Erinacines

Lipophilic diterpenoids concentrated in the mycelium of Lion's Mane. They are able to cross the blood-brain barrier, a rare and important property, where they have been shown in models to suppress neuroinflammation and block NF-kB activation in brain tissue.

Hericenones

Aromatic compounds found in the fruiting body. They inhibit COX-2 and iNOS, reducing both prostaglandin E2 and nitric oxide, two of the most studied mediators of chronic inflammatory pain and oxidative damage.

Beta-Glucans

Polysaccharides that modulate the immune response by binding to pattern recognition receptors on macrophages and dendritic cells. They have been observed to downregulate pro-inflammatory cytokines while supporting the gut barrier, which itself plays a role in systemic inflammation.

Ergothioneine

A rare amino acid antioxidant found in high concentrations in medicinal mushrooms. It is so biologically useful that the body has evolved a dedicated cellular transporter (OCTN1) to absorb and retain it. It scavenges reactive oxygen species and helps protect mitochondrial function.

Inflammation and the Brain

Neuroinflammation, inflammation within the central nervous system, is now understood to play a central role in cognitive decline, mood disorders and neurodegenerative disease. Microglial cells, the brain's resident immune cells, can contribute to neuronal damage when they remain chronically activated.

This is where Lion's Mane becomes particularly relevant. Because erinacines can cross the blood-brain barrier, they may act on neuroinflammation directly rather than only at the periphery. In a mouse model of Alzheimer's disease, erinacines were reported to reduce neuroinflammation and lower IL-1beta expression, one of the key cytokines implicated in neurodegeneration.

It is worth being precise here. That is an animal finding, not a human outcome, and Lion's Mane is a food supplement, not a treatment for any disease. What the research describes is a plausible mechanism, supported by early signals, that warrants larger human study.

What This Means for You

  • Appears to act on NF-kB, COX-2 and iNOS, and Nrf2: three distinct inflammatory and antioxidant pathways.
  • Key compounds can cross the blood-brain barrier, with the potential to influence neuroinflammation directly.
  • May support the body's own antioxidant defence system (SOD, GPx) rather than only suppressing the immune response.
  • Modulates immune activity via beta-glucans without broad immune suppression.
  • Supported by a growing body of pre-clinical evidence, with promising early clinical signals in cognitive and gastrointestinal research.

Honesty matters more than hype. The current anti-inflammatory evidence base for Lion's Mane is predominantly pre-clinical, drawn from cell studies and animal models. Several clinical trials in neurodegeneration and gastrointestinal health show encouraging early signals, but larger, longer human trials targeting systemic inflammation specifically are still needed. The mechanistic evidence, by contrast, is well established and consistent.

Why Quality Matters

The erinacines, hericenones and beta-glucans responsible for these effects are concentrated in specific parts of the mushroom, and are highly sensitive to cultivation method, extraction process and standardisation. The fruiting body versus mycelium distinction matters. Extraction matters. Concentration matters. A supplement with low or unstandardised levels of these bioactives will not replicate the conditions seen in the research.

This is why we built STRONOS. 10:1 fruiting body extract. 2,000mg per serving. BRCGS AA certified manufacturing. Precision formulation, every batch. Not as a marketing claim, but as the entire point.

References

  1. Contato, A.G. & Conte-Junior, C.A. Nutrients, 17(8), 1307, 2025.
  2. Mori, K. et al. Phytotherapy Research, 23(3), 367–372, 2009.
  3. Lee, K.F. et al. Journal of Ethnopharmacology, 2014.
  4. Roda, E. et al. Nutrients, 2021.
  5. Luo, J., Ganesan, K. & Xu, B. Journal of Fungi, 10, 215, 2024.

This article is for informational purposes only and is not intended as medical advice. Food supplements are not a substitute for a varied, balanced diet and a healthy lifestyle. If you have concerns about inflammation or any health condition, please speak to a qualified healthcare professional. Always consult a healthcare professional before making changes to your supplement routine.

Back to blog